{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG|Positive|Treatment of renal-cell carcinoma" in comments (approximate match)
Showing 1 - 3 of 3 results
Status:
Investigational
Source:
NCT01380249: Phase 1 Interventional Completed Malignant Solid Tumours
(2011)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
NCT03983954: Phase 1 Interventional Recruiting ER+ Breast Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2012)
Source URL:
First approved in 2011
Source:
21 CFR 355
Source URL:
Class:
PROTEIN
